Libraries of human rhinovirus-based HIV vaccines generated using random systematic mutagenesis

Area of Science:

• Virology
• Immunology
• Vaccine Development

Background:

• Human rhinovirus (HRV) is an immunogenic, nonpathogenic virus.
• Developing an effective vaccine against Human Immunodeficiency Virus (HIV) remains a global health priority.

Purpose of the Study:

• To engineer HRV to display HIV-1 immunogens for potential AIDS vaccine development.
• To create viable and immunogenic chimeric viruses that present HIV-1 V3 loop epitopes.

Main Methods:

• Utilized random systematic mutagenesis to generate libraries of chimeric HRV14 displaying HIV-1 V3 loop sequences.
• Incorporated randomized amino acid residues flanking the HIV epitope to accommodate various conformations.
• Designed libraries reflecting natural HIV-1 V3 loop diversity and employed neutralizing anti-HIV-1 antibodies for selection.

Main Results:

• Generated chimeric HRV libraries with randomized flanking residues, observing nonrandom residue distribution suggesting structural constraints.
• Identified chimeras that reacted with neutralizing anti-HIV-1 V3 loop antibodies, confirming successful transplantation of antigenicity.
• Developed methods to isolate antigenic chimeras as potential vaccine candidates.

Conclusions:

• Engineered HRV can present functional HIV-1 V3 loop epitopes, demonstrating a viable strategy for chimeric vaccine development.
• The approach allows for the creation of immunogenic hybrids with potential to elicit protective immune responses against HIV.
• Further selection and characterization of these chimeras are ongoing to advance their development as AIDS vaccine candidates.